- Home
- CSWI vs CRNX Comparison
CSWI vs CRNX Comparison
Compare CSWI & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSWI
- CRNX
- Stock Information
- Founded
- CSWI 2014
- CRNX 2008
- Country
- CSWI United States
- CRNX United States
- Employees
- CSWI N/A
- CRNX N/A
- Industry
- CSWI Home Furnishings
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- CSWI Industrials
- CRNX Health Care
- Exchange
- CSWI Nasdaq
- CRNX Nasdaq
- Market Cap
- CSWI 4.9B
- CRNX 5.2B
- IPO Year
- CSWI N/A
- CRNX 2018
- Fundamental
- Price
- CSWI $290.19
- CRNX $34.73
- Analyst Decision
- CSWI Buy
- CRNX Strong Buy
- Analyst Count
- CSWI 4
- CRNX 12
- Target Price
- CSWI $384.67
- CRNX $73.36
- AVG Volume (30 Days)
- CSWI 140.3K
- CRNX 937.9K
- Earning Date
- CSWI 05-22-2025
- CRNX 05-08-2025
- Dividend Yield
- CSWI 0.33%
- CRNX N/A
- EPS Growth
- CSWI 33.74
- CRNX N/A
- EPS
- CSWI 8.33
- CRNX N/A
- Revenue
- CSWI $858,612,000.00
- CRNX $1,039,000.00
- Revenue This Year
- CSWI $13.33
- CRNX $394.51
- Revenue Next Year
- CSWI $8.17
- CRNX $699.82
- P/E Ratio
- CSWI $34.83
- CRNX N/A
- Revenue Growth
- CSWI 10.41
- CRNX N/A
- 52 Week Low
- CSWI $226.05
- CRNX $31.84
- 52 Week High
- CSWI $436.50
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- CSWI 40.37
- CRNX 46.96
- Support Level
- CSWI $294.27
- CRNX $32.90
- Resistance Level
- CSWI $314.79
- CRNX $36.45
- Average True Range (ATR)
- CSWI 8.89
- CRNX 1.42
- MACD
- CSWI 2.01
- CRNX 0.26
- Stochastic Oscillator
- CSWI 21.19
- CRNX 51.49
About CSWI CSW Industrials Inc.
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.